Minapharm Pharmaceuticals SAE · MIPH.CA

Minapharm Pharmaceuticals SAE is an Egypt-based pharmaceuticals business in the healthcare sector, listed on the Egyptian Exchange under ticker MIPH.CA. Minapharm Pharmaceuticals SAE is an Egypt-based company engaged in the production and distribution of pharmaceutical products. Minapharm Pharmaceuticals SAE’s production falls into seven lines, namely Gastroenterology, Ophthalmology, Cardiology, Biogenetics, Dermatology, Dermatology, Orthopedic and Miscellaneous products such as betolvex, broncho-vaxom adult, broncho-vaxom infantile, burinex, chlorhexidine tulle, chlorhexidine tulle, ciloprine, daktacort cream, daktarin cream, desatura, dicynone, among others. Minapharm is in cooperation with several international pharmaceutical companies and it distributes its products within and outside Egypt. Its investment profile is best assessed through product quality, regulatory compliance, distribution, pricing, and demand from Egypt’s healthcare market. Key analysis points include business model clarity, durability of revenue sources, cost control, cash conversion, leverage, shareholder structure, and the consistency of public disclosures over time.